M. Sellos-Moura

Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.

J. Ruiz, M. Sellos-Moura, S. Barzegar, 2011, Journal of immunological methods.

Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial

H. Mandel, P. Sedgwick, S. Rahman, 2019, Journal of clinical medicine.

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

R. Schiffmann, R. Brady, T. Liang, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

R. Schiffmann, R. Brady, T. Liang, 2000 .

Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison

D. Irwin, M. Sellos-Moura, D. Lapidus, 2020, BMC Health Services Research.

Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy

C. Krarup, M. Duno, J. Månsson, 2015, Annals of clinical and translational neurology.

Rapid, single-step assay for Hunter syndrome in dried blood spots using digital microfluidics.

Ramakrishna Sista, Vamsee K Pamula, Allen E Eckhardt, 2011, Clinica chimica acta; international journal of clinical chemistry.

Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria?

D. Irwin, M. Sellos-Moura, D. Lapidus, 2020, Molecular genetics and metabolism.

Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy

B. Bax, M. Sellos-Moura, C. Gasson, 2018, Molecular therapy. Methods & clinical development.